Sun, Dec 22, 2024 | Updated 03:27 IST
Sola Civil Hospital in Ahmedabad begins Phase-3 trial of Covaxin
Nov 27, 2020
Ahmedabad (Gujarat) [India], November 27 : The Phase-3 trial of COVID-19 vaccine candidate Covaxin begun with five volunteers at Sola Civil Hospital in Ahmedabad...
Phase 3 clinical trials of Covaxin shows 81 per cent efficacy, says Bharat Biotech
Mar 03, 2021
Hyderabad (Telangana) [India], March 3 : Bharat Biotech on Wednesday released results of Phase 3 clinical trials of its coronavirus vaccine Covaxin, with the...
DCGI likely to approve phase 3 trial data of Covaxin on Tuesday
Jun 22, 2021
New Delhi [India], June 22 : The Drugs Controller General of India (DCGI) is likely to approve Phase III trial data of Covaxin...
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine efficacy of 78.8 pc against COVID-19
Jul 03, 2021
Hyderabad (Telangana) [India], July 3 : Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial...
COVID-19: Phase-3 trial of COVAXIN to begin in UP's Lucknow, Gorakhpur from October
Sep 25, 2020
Lucknow (Uttar Pradesh) [India], September 25 : The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start...
COVID-19: Phase 3 of COVAXIN to check its effectiveness to prevent disease
Nov 21, 2020
Bhubaneswar (Odisha) [India], November 21 : In phase 3, COVAXIN's effectiveness to prevent the disease (coronavirus) will be checked, said Dr. E Venkata Rao,...
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin phase-3 clinical trials
Jan 07, 2021
COVAXIN phase 3 full trial data will be made public in July: Bharat Biotech
Jun 09, 2021
Delhi HC refuses to put stay on Phase 2-3 clinical trials of Covaxin for 2-18 age group
May 19, 2021
FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says Ocugen
May 23, 2022
Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID-19, says Lancet
Nov 12, 2021
Lancet Infectious Diseases study compare well with phase 3 clinical trials of COVAXIN: Bharat Biotech
Nov 25, 2021
Related Videos
No Result Found